A passing of the baton. Jie Xue’s successor, Kelly Londy, had the opportunity to spend several weeks with Jie as part of the leadership transition.
previous arrow_PURPLE.svgnext arrow_PURPLE.svg
Subscribe Now
Manage Subscription
FOLLOW US
Contact Us Cookie PreferencesPrivacy PolicyCalifornia Privacy Policy
Do Not Sell or Share My Personal InformationTerms & ConditionsSecurity
© 2024 GE HealthCare. GE is a trademark of General Electric Company. Used under trademark license.
News

GE HealthCare MR leadership change sees the return of a familiar face

005-008 Page 5 Passing the Baton.jpg
A passing of the baton. Jie Xue’s successor, Kelly Londy, had the opportunity to spend several weeks with Jie as part of the leadership transition.
Earlier this year, a change in the leadership of the GE HealthCare MR business was announced. After 25 years with GE HealthCare and 10 years with the MR business, Jie Xue announced her departure, leaving behind an enviable legacy both within the organization and in the industry as a whole. Jie’s mantras that “image is everything” and “innovation goes to everyone” permeated GE HealthCare MR, with the organization ushering in the new era of artificial intelligence (AI) that is rapidly transforming the MR industry. Within four years, AIR™ Recon DL, Sonic DL™ and other AI-powered innovations are now running on thousands of GE HealthCare MR scanners, ranging from 20-year-old legacy 1.5T to brand new SIGNA™ 7.0T systems, benefiting tens of thousands of patients every single day.
Jie remarked, “The last four and a half years we shared were nothing short of extraordinary — we were hit fast and furious by a pandemic, a supply chain disruption and the arrival of AI. Together with all our colleagues and partners, we fought through unprecedented challenges, stayed on course to innovate and delivered on our mission to Unleash the Power of SIGNA™ MR to Deliver the Best Patient Care!
GE HealthCare is pleased to welcome back Kelly Londy as the newly appointed President & CEO, Global MR, succeeding Jie Xue. Kelly returned to the MR business in March, bringing with her many years of experience in medical device leadership positions. Most recently, Kelly served as the President & CEO of Nuvo Group, an AI-based maternal-fetal management and monitoring company. Kelly has also held Chief Executive and Operation Officer roles with Innoblative Designs (CEO), Lumicell (CEO) and Accuray (COO). Additionally, until coming back to GE HealthCare, Kelly has also served on the Board of Directors for CMR Surgical and Elekta.
Kelly previously worked at GE HealthCare as an MR Sales Specialist and as the Vice President & General Manager for the United States Molecular Imaging Business.
No stranger to MR, Kelly began her career in the Radiology Department at the University of Michigan Hospitals. Her passion for advancing healthcare by leading companies that develop innovative diagnostic and treatment technologies resonates throughout her career. This is an exciting time for GE HealthCare’s MR business, and the organization looks forward to working with Kelly to continue delivering systems and solutions that will enable greater patient access to MR imaging.
“I am passionate about ensuring patients have increased access to healthcare and providing the best solutions clinicians need to deliver the highest quality, expeditious care,” says Kelly. “With the array of outstanding capabilities in SIGNA™ MR today, I’m excited to shepherd the next generation of SIGNA™ MR for tomorrow to expand access, improve care possibilities and further advance MR imaging.”
DOWNLOAD ARTICLE HERE
GE-endmark-2.png